| Literature DB >> 35328532 |
Samayitree Das1, Sharon D'Souza2, Bhavya Gorimanipalli2, Rohit Shetty2, Arkasubhra Ghosh1, Vrushali Deshpande1.
Abstract
Infection mediated ocular surface stress responses are activated as early defense mechanisms in response to host cell damage. Integrated stress responses initiate the host response to different types of infections and modulate the transcription of key genes and translation of proteins. The crosstalk between host and pathogen results in profound alterations in cellular and molecular homeostasis triggering specific stress responses in the infected tissues. The amplitude and variations of such responses are partly responsible for the disease severity and clinical sequelae. Understanding the etiology and pathogenesis of ocular infections is important for early diagnosis and effective treatment. This review considers the molecular status of infection mediated ocular surface stress responses which may shed light on the importance of the host stress-signaling pathways. In this review, we collated literature on the molecular studies of all ocular surface infections and summarize the results from such studies systematically. Identification of important mediators involved in the crosstalk between the stress response and activation of diverse signaling molecules in host ocular surface infection may provide novel molecular targets for maintaining the cellular homeostasis during infection. These targets can be then explored and validated for diagnostic and therapeutic purposes.Entities:
Keywords: bacterial conjunctivitis; bacterial keratitis; fungal conjunctivitis; fungal keratitis; gene expression; host stress response; ocular surface infections; proteins; viral conjunctivitis; viral keratitis
Mesh:
Year: 2022 PMID: 35328532 PMCID: PMC8952005 DOI: 10.3390/ijms23063111
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Schematic representation of changes in ocular tissue in: (A) Conjunctivitis: Inflammation of conjunctiva with infiltration of immune cells (neutrophils, lymphocytes, mast cells) which results in disruption in structure and inflammation leading to clinical symptoms and signs. (B) Keratitis: Infection of the cornea by different pathogens results in formation of a corneal ulcer or infiltrate with disruption in Bowman’s layer, epithelial and stromal edema with presence of inflammatory cells. Severe cases can also have inflammation in the anterior chamber in the form of hypopyon and keratic precipitates on the endothelium. (C) H&E staining of section on the right shows the histopathology of an infected cornea illustrating disruption of the Bowman’s layer and dense infiltration of the stroma by polymorphonuclear cells.
Types of ocular infections and their pathophysiology.
| Ocular | Causative Agent | Sign/Symptoms | Treatment |
|---|---|---|---|
| Bacterial |
| Symptoms: Eye pain, blurred vision, photophobia, and discharge | Topical antibiotics are used based on microbiological sensitivity. Combination of medications may be required |
| Fungal |
Filamentous fungi ( Yeast ( | Symptoms: Eye pain, blurred vision, photophobia, and discharge | Topical antifungal medications as per severity of infections. Natamycin and voriconazole are the most common medications used. Oral antifungals of the azole group are also given for more severe infections |
| Viral Keratitis |
| Symptoms: Discomfort, watering, itching, burning, and pain in the eye | Topical acyclovir and ganciclovir for epithelial forms of disease. Stromal viral keratitis requires topical steroids. Viral endothelitis and recurrent stromal involvement require oral antiviral medications |
| Bacterial |
| Symptoms: Unilateral or bilateral redness, classically purulent discharge, photophobia, tearing, irritation, stinging, burning, and discomfort | Acute bacterial conjunctivitis is usually treated with topical fluoroquinolones, macrolides, and aminoglycosides. Tetracycline and macrolides are used to treat chlamydia |
| Trachoma |
Active disease: Mucopurulent discharge, superior epithelial keratitis, pannus formation, superior conjunctival follicles on upper limbus Chronic disease: Conjunctival scarring, corneal opacification, cicatricial entropion, and trichiasis | SAFE strategy: S: Surgery in case of trichiasis, A: Antibiotics (azithromycin and erythromycin) for C. trachomatis infection, F: Facial cleanliness, E: Environmental change for sanitation | |
| Viral |
| Symptoms: Unilateral or bilateral watering, redness, discomfort, and photophobia | Symptomatic relief and cold compresses. Topical antibiotics to prevent secondary infection and topical steroids for severe inflammation in conjunctivitis |
Figure 2Slit-lamp photographs showing clinical features of different keratitis. (a) Fungal keratitis showing classic feathery margins and hypopyon. (b) Bacterial keratitis showing central dense infiltrate with hypopyon in the anterior chamber. (c) Acanthamoeba keratitis showing ring infiltrate in the cornea. (d) Herpes viral epithelial keratitis showing dendrite stained with fluorescein dye seen under cobalt blue filter. (e) Disciform keratitis shown with slit image of the cornea showing central stromal edema with keratic precipitates on the endothelium. (f) Recurrent herpes viral stromal keratitis with peripheral deep vascularization and central stromal edema and scarring. (g) In vivo confocal microscopy (IVCM) image of a cornea with Acanthamoeba keratitis showing hyperreflective cyst form of acanthamoeba and inflammatory cells (red circles). Panels shown are representative IVCM images with a depth of 31 microns. (h) IVCM image of a cornea with fungal keratitis showing fungal filaments (yellow arrows). Panels shown are representative IVCM images a depth of 320 microns. Confocal images were taken using Rostock Corneal Module/Heidelberg Retina Tomograph II (RCM/HRT2; Heidel Engineering GmBH, Dossenheim, Germany). Scale bar represents 50 µm.
Host response proteins in ocular microbial infections.
| Ocular Disease | Techniques Used | Host Molecular Responses | References |
|---|---|---|---|
| Bacterial |
SDS-PAGE, Western blot, ELISA Western blot, ELISA, protein array, and LC-MS/MS ELISA and Western blot |
α-toxin, β-toxin Upregulated soluble factors: IL-4, IL-6, and IL-10 Upregulated soluble factors in infected cornea: IL-6, IL-1β, IFN-γ, IL-12 p40, TNF-α Upregulated soluble factors in immortalized cell lines: IL-8, IL-6, and GRO. Upregulated proteins: 133 pathogenic and virulent proteins, 2 non-ribosomal peptide synthetases (NRPSs), L-2-Amino-4-methoxy- |
Callegan, M. C. et al. (1994) Sewell, A. et al. (2014) Bouhenni, R. et al. (2015) |
| Fungal keratitis |
MADI-TOF MS 2D-DIGE with LC-MS/MS 1D-PAGE with LC-MS/MS 2D-PAGE with MALDI-TOF MS 2D-DIGE Multiplex bead-based Luminex liquid protein array |
Upregulated proteins: Prolactin inducible protein and serum albumin precursor. Downregulated proteins: Cystatin S precursor, cystatin SN precursor, cystatin, and human tear lipocalin Upregulated proteins: Haptoglobin, apolipoprotein, albumin. Downregulated proteins: Lacritin Host defense proteins: CRP, Sap, lectins, MBL associated proteins, complement proteins Wound healing proteins: thrombin, plasminogen, heat shock proteins Increased expression of IL-1β, IL-6, IL-8, and IFN-γ in aqueous humor |
Kandhavelu, J. et al. (2017) Ananthi, S. et al. (2008) Kandhavelu, J. et al. (2017) Calvillo-Medina, R. P. (2019) Parthiban, N. et al. (2019) Zhang, Y. et al. (2018) |
| Viral keratitis |
iTRAQ coupled to LC–MS/MS Nano-LC/MS and ELISA Enzyme immunosorbent assay (EIA) |
HSV keratitis:
Upregulated proteins: Beta-globin, cathepsin B, vimentin, copine 3 Downregulated proteins: Sorting nexin 4, neurolysin, syntaxin 12 Upregulated proteins: IL1A, IL12B, DEFB4A, and CAMP 15-fold higher expression of Substance P |
Berard, A. R. et al. (2015) Yang, H. et al. (2020) Twardy, B.S. et al Brandon, S. (2011) |
| Viral | ELISA | Elevated levels of hyaluronic acid (HA) can acts as a rapid diagnostic marker | Dreyfuss, J.L. et al Juliana (2015) |
Host response genes in ocular microbial infections.
| Ocular Infection | Techniques | Host Molecular Responses | References |
|---|---|---|---|
| Viral Keratitis |
RNA isolation and real-time PCR PCR, TaqMan RT-PCR, qRT-PCR MicroRNA expression by Northern blot SiRNA expression targeting glycoprotein D and E Knockdown of TRIM32 expression in HCE HSV injection and preparation of MIP-1α deficient (−/−) mice and their wild-type (+/+) |
IL-17 HSV-1 latency associated transcript (LAT) miR-155 Prophylactic role of small interfering RNA Upregulation of TRIM32 aggravates HSV keratitis by increased HSV-1 replication MIP-1α deficient mice show decreased HSK infection, plays a positive role in development of HSV keratitis |
Maertzdorf, J. et al. (2002) Tormanen, K. et al. (2019) Banerjee, A. et al. (2010) Chen, L. et al. (2021) Cui, H. et al. (2017) Terrence, M. T. et al. (1998) |
| RNA sequencing, RT-qPCR | Type I interferon (IFN) | Smith, J. R. et al. (2017) | |
| Bacterial keratitis |
Comparative analysis of differentially expressed genes (DEGs) by microarray data. Genotyping performed by pyrosequencing RT-PCR Pglyrp-1(-/-) mice Microarray transcriptomic profiling RT-PCR RT-PCR RNA isolation and qPCR Silencing HMGB1 by siRNA |
SNPs in minor allele G associated with High expression of Overexpression of defensins (mBD2 and 3), cathelicidin-related antimicrobial peptides (Cnlp) and Pglyrp-1. Upregulated cytokines in fungal and bacterial keratitis: MMPs (MMP1, MMP7, MMP10, MMP12), proinflammatory cytokines (IL1B, TNF), and PRRs (TLR2, TLR4), Increased expression of HIF1 gene in bacterial keratitis Increased expression of AnxA1 and fpr2, mediators in homeostasis of inflammation Anti-inflammatory role of thrombomodulin suggests recombinant TM (rTM) results in protection against keratitis Overexpression of NLRC3 attenuated Downregulation of high mobility group box 1 (HMGB1) improves bacterial keratitis |
Tian, R. et al. (2020) Carnt, N. A. et al. (2019) Gowda, R.N. et alRanjita et al. (2015) Chidambaram, J. et al. (2017) Boyd, K. et alDa Silva (2019) Sharon, A. et al. (2015) Guo, L. et al. (2017) Hazlett, L. D. et al. (2016) |
| Fungal keratitis |
Real-time PCR Transcriptome analysis by RNA sequencing, validation with qRT-PCR RT-PCR |
27 genes involved in the adhesion, initiation, maturation, and dispersal stages of biofilm. Markers of FK: Inflammatory cytokine genes: IL-1B, IL-6, TNF-α, Enriched pathways: Wnt, cGMP–PKG, and Hippo signaling pathways Higher expression of Mincle, which helps in corneal resistance and host immune response |
Ranjith, K. et al. (2018) Zhang, Q. et al. (2020) Zhao, G. et al. (2015) |
|
| MIP-2 and myeloperoxidase (MPO) assays | MIP-2 induces neutrophil infiltration which acts as a therapeutic strategy in | Hurt, M. et al. (2001) |
Figure 3Drug–target interaction network constructed using DrugBank database. Drugs and targets are presented by circles and squares, respectively. Drug–target interactions are represented by the lines connecting related drugs and targets. Green (square) targets represent bacterial infection, blue (square) targets represents viral infection, and red (square) targets represent fungal infection.